Exercise during GLP-1 therapy supports muscle preservation, improves metabolic health, and enhances overall wellbeing
For stacking strategies, see our peptide stacking guide
Most people notice appetite suppression within days of their first dose
Changes from baseline in cardiovascular, metabolic, and inflammatory biomarkers among GLP-1 drug users were as follows: Triglycerides: -16.4 mg/dL LDL cholesterol: -7.3 mg/dL HbA1c: -0.3 percentage points CRP: -0.6 mg/dL ESR: -3.0 mm/hr These were all numerically greater than corresponding changes for non-users, but often the differences didn't reach statistical significance
Side effects live in the same app as your dose-day, shot or pill routine, food, water, weight, and progress logs